Register to receive a free Europe Market For Orthopedic Biomaterials – 2015 report synopsis and brochure
BIOMATLANTE (Vigneux de Bretagne), a medical device company specialized in bone regeneration, announced the CE regulatory approval of EZ CURE™ Strip and EZ CURE Plug, a combination of highly purified collagen Type I with its MBCP™ core technology, to extend its range of synthetic bone graft substitutes. BIOMATLANTE will showcase those products at the Eurospine Conference, held 2-4 September 2015 in Copenhagen, Denmark and at the European Association for Osseointegration (EAO) meeting, held 24-26 September 2015 in Stockholm, Sweden.
Main features include:
- A versatile mineralized sponge which absorbs and retains biological fluids.
- High permeability stemming from its unparalleled porosity
- Homogeneous mixture of MBCP™ and highly purified Type I Collagen
The EZ Cure™ Strip and Plug complete the EZ CURE™ line of Collagen products marketed by BIOMATLANTE.
Based near Nantes, France, Biomatlante specializes in synthetic biomaterials for bone regeneration and is a world leader in bone graft technologies, selling its products in over 50 countries. Biomatlante’s products are routinely used in orthopedics and trauma surgery, in spine and dental surgery. BIOMATLANTE strives to integrate a strategy of strong innovation and product development required to meet and exceed the needs of today’s market. Our R&D collaborates closely with universities and research centers across the world, bringing together competences in innovation, technological transfers of new biomaterials, surgical technologies and providing the intellectual protection required to foster long-term projects.
For Further Information
More on the orthopedic biomaterials market in Europe can be found in the report series published by iData entitled Europe Market For Orthopedic Biomaterials . This report covers Europe markets for Bone Graft Substitutes, Allografts, Synthetic Bone Graft Substitutes, Demineralized Bone Matrix devices, Hyaluronic Acid Viscosupplementation, Bone Morphogenetic Protein Growth Factors, and Autologous Chondrocyte Implantation.
The iData series on the market for orthopedic biomaterials covers the U.S., China, Japan, India, South Korea, Australia, U.K., Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.